Washington is attempting to compel drug manufacturers to move their production to the United States. Last year, Trump warned drug manufacturers of 100% tariffs if they refused to establish factories in the US.
As per sources from FT, the tariffs will be imposed on medications from firms that haven't entered into agreements with the White House. Officials might declare their enforcement as soon as Thursday.
European firms AstraZeneca and Novo Nordisk are among those that have reached agreements with the Trump administration to boost investment in the US and lower drug prices.
Import duties from nations that have negotiated trade agreements with the White House will be confined to the conditions outlined in those deals, the sources indicate. Last year, the US consented to limit tariffs on EU pharmaceuticals to 15%.
source: ft.com
As per sources from FT, the tariffs will be imposed on medications from firms that haven't entered into agreements with the White House. Officials might declare their enforcement as soon as Thursday.
European firms AstraZeneca and Novo Nordisk are among those that have reached agreements with the Trump administration to boost investment in the US and lower drug prices.
Import duties from nations that have negotiated trade agreements with the White House will be confined to the conditions outlined in those deals, the sources indicate. Last year, the US consented to limit tariffs on EU pharmaceuticals to 15%.
source: ft.com
